Insulin Analog class drugs

17 results

  • Admelog

    (insulin lispro)
    Sanofi-Aventis U.S. LLC
    Usage: ADMELOG is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.

  • Apidra

    (insulin glulisine)
    sanofi-aventis U.S. LLC
    Usage: APIDRA is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.

  • Basaglar

    (Insulin glargine)
    Eli Lilly and Company
    Usage: BASAGLAR® is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus, and in adults with type 2 diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.

  • Fiasp

    (insulin aspart injection)
    Novo Nordisk
    Usage: FIASP is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.

  • Humalog

    (Insulin lispro)
    Eli Lilly and Company
    Usage: HUMALOG is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.

  • Humalog

    (Insulin lispro)
    Eli Lilly and Company
    Usage: HUMALOG Mix75/25 is indicated for improving glycemic control in adults with diabetes mellitus. It has fixed proportions of rapid-acting and intermediate-acting insulins, limiting adjustments for basal and prandial doses.

  • Humalog

    (Insulin lispro)
    Eli Lilly and Company
    Usage: HUMALOG Mix50/50 is indicated for improving glycemic control in adults with diabetes mellitus. However, it has limitations as the fixed proportions of rapid-acting and intermediate-acting insulins prevent adjustments for basal and prandial dosing.

  • Lantus

    (insulin glargine)
    sanofi-aventis U.S. LLC
    Usage: LANTUS is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.

  • Levemir

    (insulin detemir)
    Novo Nordisk
    Usage: LEVEMIR is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.

  • Lyumjev

    (Insulin lispro-aabc)
    Eli Lilly and Company
    Usage: LYUMJEV® is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.